| Clinical and biomarker changes in dominantly inherited Alzheimer's disease RJ Bateman, C Xiong, TLS Benzinger, AM Fagan, A Goate, NC Fox, ... New England Journal of Medicine 367 (9), 795-804, 2012 | 3679 | 2012 |
| Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... The Lancet Neurology 12 (4), 357-367, 2013 | 1985 | 2013 |
| Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. CL Masters, G Multhaup, G Simms, J Pottgiesser, RN Martins, ... The EMBO journal 4 (11), 2757-2763, 1985 | 1326 | 1985 |
| High performance plasma amyloid-β biomarkers for Alzheimer’s disease A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ... Nature 554 (7691), 249-254, 2018 | 1287 | 2018 |
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ... Neurobiology of aging 31 (8), 1275-1283, 2010 | 1063 | 2010 |
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 933 | 2011 |
| Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease B Rumble, R Retallack, C Hilbich, G Simms, G Multhaup, R Martins, ... New England Journal of Medicine 320 (22), 1446-1452, 1989 | 831 | 1989 |
| The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of … KA Ellis, AI Bush, D Darby, D De Fazio, J Foster, P Hudson, ... International psychogeriatrics 21 (4), 672-687, 2009 | 776 | 2009 |
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 618 | 2019 |
| Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor L Xie, E Helmerhorst, B Plewright, W Van Bronswijk, R Martins The Journal of Neuroscience 22 (RC221), 1-5, 2002 | 504 | 2002 |
| A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic … L Davies, B Wolska, C Hilbich, G Multhaup, R Martins, G Simms, ... Neurology 38 (11), 1688-1688, 1988 | 491 | 1988 |
| Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease IJ Martins, E Hone, JK Foster, SI Sünram-Lea, A Gnjec, SJ Fuller, D Nolan, ... Molecular psychiatry 11 (8), 721-736, 2006 | 463 | 2006 |
| Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis DC Ryman, N Acosta-Baena, PS Aisen, T Bird, A Danek, NC Fox, A Goate, ... Neurology 83 (3), 253-260, 2014 | 454 | 2014 |
| Relationship between atrophy and β‐amyloid deposition in Alzheimer disease G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ... Annals of neurology 67 (3), 317-324, 2010 | 431 | 2010 |
| Blood-based protein biomarkers for diagnosis of Alzheimer disease JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ... Archives of neurology 69 (10), 1318-1325, 2012 | 430 | 2012 |
| White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network S Lee, F Viqar, ME Zimmerman, A Narkhede, G Tosto, TLS Benzinger, ... Annals of neurology 79 (6), 929-939, 2016 | 425 | 2016 |
| Increased risk of cognitive impairment in patients with diabetes is associated with metformin EM Moore, AG Mander, D Ames, MA Kotowicz, RP Carne, H Brodaty, ... Diabetes care 36 (10), 2981-2987, 2013 | 425 | 2013 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 409 | 2011 |
| Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β CS Atwood, ME Obrenovich, T Liu, H Chan, G Perry, MA Smith, ... Brain Research Reviews 43 (1), 1-16, 2003 | 406 | 2003 |
| The amyloid precursor protein of Alzheimer's disease is released by human platelets. AI Bush, RN Martins, B Rumble, R Moir, S Fuller, E Milward, J Currie, ... Journal of Biological Chemistry 265 (26), 15977-15983, 1990 | 403 | 1990 |
